Back to Search
MICHAEL HOLLINGSHEAD, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1811102445IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
0101271395(VA)200701355(NC)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms.
PMID 17631503·J Biol Chem·2007
7-preclinical
In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.
PMID 15791458·Cancer Chemother Pharmacol·2005
7-preclinical
A potential role for imaging technology in anticancer efficacy evaluations.
PMID 15120044·Eur J Cancer·2004
7-preclinical
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
PMID 19636271·J Pediatr Hematol Oncol·2009
7-preclinical
Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction.
PMID 19533749·Int J Cancer·2009
8-other
Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
PMID 19084416·Bioorg Med Chem·2009
7-preclinical
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
PMID 19232100·BMC Cancer·2009
7-preclinical
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
PMID 19584228·Mol Cancer Ther·2009
7-preclinical
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.
PMID 19175523·Pigment Cell Melanoma Res·2009
7-preclinical
Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
PMID 18199555·Cancer Res·2008
7-preclinical
Preclinical modeling of a phase 0 clinical trial: qualification of a pharmacodynamic assay of poly (ADP-ribose) polymerase in tumor biopsies of mouse xenografts.
PMID 18980982·Clin Cancer Res·2008
7-preclinical
CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.
PMID 18854445·AJNR Am J Neuroradiol·2008
5-case
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
PMID 18394172·Mol Cancer·2008
7-preclinical
Acute necrotizing encephalopathy of childhood: typical findings in an atypical disease.
PMID 18415059·Pediatr Radiol·2008
5-case
Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts.
PMID 17722994·Radiat Res·2007
7-preclinical
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
PMID 18199854·Mol Interv·2007
6-review
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
PMID 17404101·Clin Cancer Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1901 TATE SPRINGS RD
LYNCHBURG, VA 24501 - Phone
- (434) 200-5047
Quick Facts
- NPI
- 1811102445
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile